Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous dexmedetomidine for comfort during bromhidrosis resection under non-general anesthesia
ChiCTR1800017409Phase 4Recruiting
- Sponsor
- Ningbo No. 2 Hospital
- Start
- Jul 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexmedetomidine in bromhidrosis (BO) (2 arms), sponsored by Ningbo No. 2 Hospital. Primary endpoints: Patient satisfaction, Ramsay sedation score and 4 more. Started Jul 2018; status: recruiting.
02
Drugs
dexmedetomidine
03
Conditions
bromhidrosis (BO)
Beyond the preview
Go deeper on ChiCTR1800017409.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1800017409.